Skip to content

Arrowhead Pharmaceuticals

US · ARWR #1569 by market cap Listed 1970
61.48 -0.06 -0.10%
Live - 5344 symbols - heartbeat 91s ago · 2026-10-08 08:29
Pre-market 60.78 -1.14%
After-hours 61.48 0.00%
Overnight 61.48 0.00%
Market cap
8.68B
P/B
18.65
EPS
-0.01
Reader sentiment Are you bullish or bearish on ARWR?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    A Quick Look at Today's Ratings for Arrowhead Pharmaceuticals(ARWR.US), With a Forecast Between $89.59 to $126
    Market Newswire · 2026/8/5
  • Rating change
    BofA Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $100
    Market Newswire · 2026/7/29
  • Goldman Sachs Maintains Arrowhead Pharmaceuticals(ARWR.US) With Hold Rating, Cuts Target Price to $74
    Market Newswire · 2026/9/24
  • Rating change
    B. Riley Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $123
    Market Newswire · 2026/7/30
  • Rating change
    RBC Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $100
    Market Newswire · 2026/8/31
  • J.P. Morgan Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating
    Market Newswire · 2026/9/16
  • Rating change
    H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $115
    Market Newswire · 2026/7/27
  • H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $120
    Market Newswire · 2026/9/22
  • Rating change
    B. Riley Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $123
    Market Newswire · 2026/8/5
  • Rating change
    B. Riley Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $101
    Market Newswire · 2026/7/23
  • Citi Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating
    Market Newswire · 2026/9/16
  • Rating change
    Analysts Are Bullish on Top Healthcare Stocks: CapsoVision, Inc. (CV), Arrowhead Pharmaceuticals (ARWR)
    TipRanks · 2026/8/31
  • Rating change
    J.P. Morgan Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $100
    Market Newswire · 2026/8/7
  • Rating change
    Citi Initiates Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Announces Target Price $108
    Market Newswire · 2026/9/8
  • Rating change
    TD Cowen Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating
    Market Newswire · 2026/8/31
  • Rating change
    Morgan Stanley Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $120
    Market Newswire · 2026/9/1
  • Citi Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $108
    Market Newswire · 2026/9/9
  • Rating change
    RBC Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $100
    Market Newswire · 2026/7/31
  • Rating change
    H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/8/7
  • Rating change
    Stifel Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $104
    Market Newswire · 2026/8/31

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:29:43 · For reference only, not investment advice and not tailored to your situation.